The banking giant is flaunting its muscle in the buzzy alts sector with the fifth iteration of a fund series launched in 2008.
Poll of roughly 1,700 Americans shows interest in Bitcoin and other cryptocurrencies on the rise, with nearly half planning to raise their exposure.
A coalition of trade associations including the Insured Retirement Institute, ACLI, and NAIFA has filed a civil suit against the contentious Retirement Security rule.
Voices from the wealth and crypto industries say the landmark crypto ETF verdict will open new doors for investors and advisors.
Nontraded REITs are facing hurdles, higher interest rates, headlines about half-empty office buildings, and investors pulling their money from products.
Not all alts shoot for the moon, warns investment strategist.
Citing bitcoin ETFs, a bipartisan group of house representatives issued the call ahead of the federal securities regulator’s pivotal decision.
The fintech's first DLT-enabled fund, launched jointly with UBS, will be the first proof point of its efficiency-boosting technology.
Executives at the online brokerage giant unveiled plans to roll out a platform that includes private credit, PE, VC, and long-short funds.
The banking behemoth is looking to extend its $3.6T asset management arm's reach in the piping-hot sector, according to sources.
Research lifts lid on RIAs' use of annuities, growth strategies, and opportunity to take wallet share from banks.
The increased focus on ESG investments is filtering down to the cultural space, says Deloitte's US art and finance lead.
Latest survey reveals all-time high of $106.7B in Q1 sales, with winning streaks in fixed-rate deferred annuities, FIAs, and RILAs.
Rate-cutting cycles happen only every few years - investors should position themselves to take advantage.
The lifetime income research provider’s collaboration brings a new tech platform to empower advisors using annuities.
New global ETF survey finds 78 percent of investors planning to boost exposures to actively managed strategies, with 70 percent eyeing more active fixed income.
The independent wealth firm is rolling out a custom platform for advisors to offer and conduct due diligence on alternative investments.
Was an all-you-can-eat shrimp promotion to blame?
The fund will invest in stocks of drug manufacturers and related industries.
Associations for life insurers and financial advisors laud the move, renews call for “sensible protections” around guaranteed lifetime income products.
